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Abstract
The objective of the research was to study the effectiveness of course application of magnesium and calcium-
containing drugs on the background of conventional therapy on the changes in the content of macronutrients in
red blood cells and the activity of matrix metalloproteinase - 9 in the patients with a co-existence of undifferentiated
connective tissue disease and gastroesophageal reflux disease.
Materials and Methods. All 75 patients with gastroesophageal reflux disease associated with undifferentiated
connective tissue disease were divided into three groups: Group I included 25 patients who received Magne-B6
at a dose of 2 tablets 3 times a day in addition to the standard background therapy with ”Panocid” at a dose of
40mg once a day; Group II comprised 25 patients who received ”Ca-D3 Nycomed” at a dose of 1 tablet 3 times a
day in addition to the standard background therapy; Group III included 25 patients who received a combination of
”Magne-B6” and ”Ca-D3 Nycomed” in addition to the standard background therapy.
Results. In Group I, the proposed complex therapy resulted in a significant increase in Mg2+ by 40.9%. Mg2+
dynamics was less significant in Group II; this index reached the level of 17.9±2.04 µg/g (p”>0.05); in its
turn, Ca2+ level increased to 80.6±2.12 µg/g (p”<0.05) in these patients. Mg2+ and Ca2+ indices showed the
most significant positive dynamics in Group III: 21.52±2.47 µg/g (p”<0.05) and 102.7±1.37 µg/g, respectively.
After combination treatment, we traced the dynamics of changes in the level of matrix metalloproteinase - 9:
it decreased by 39.45% in Group I, by 35.3% in Group II, by 53.18% in Group III and reached the level of
1689.266±14.89 pg/ml, approaching the indicators of the control group.
Conclusions. Based on the data obtained, it can be argued that simultaneous addition of ”Magne-B6” and
”Ca-D3 Nikomed” to the standard therapy for gastroesophageal reflux disease in the patients with undifferentiated
connective tissue disease contributed to a significant decrease in the level of matrix metalloproteinase-9 resulting
in reduced degradation and increasing synthesis of new connective tissue components.
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Problem statement and analysis of
the latest research
Micronutrients and macronutrients being cofactors
of matrix metalloproteinases (MMP) play an im-
portant role in the synthesis of the basic structural
proteins of connective tissue [1]. In particular, Mg
influences the activity of enzymes involved in the
formation of collagen providing flexibility and elas-
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ticity to the connective tissue matrix [2]. Pyridoxine
is also very important for the metabolic support of
connective tissue function and stimulation of col-
lagen formation [3, 4]. Protein synthesis of con-
nective tissue is slowed in case of both magnesium
and pyridoxine deficiency [5]. Mg deficiency con-
tributes to the increase in MMP activity and thus
causes aggressive degradation of collagen fibers and
loss of connective tissue strength. The abnormali-
ties of tissue structure manifesting themselves as a
decrease in the content of certain types of collagen
or their ratio distortion are considered as connective
tissue disease (CTD).
The probability of internal organ pathology in-
creases in CTD. Gastrointestinal tract (GI) is one
of the systems that are most often involved in the
pathological process of undifferentiated connective
tissue disease (UCTD), especially the esophagus.
Cardiac insufficiency is one of UCTD manifesta-
tions and there is a direct relation between UCTD
degree and the incidence of gastroesophageal re-
flux [6]. Over recent years, experimental works
have also started to appear showing that magnesium
deficiency may affect the development of gastroe-
sophageal reflux disease (GERD). Smooth muscle
contraction is known to underlie the regulation of
vascular tone in general, and the balance of Ca2+
and Mg2+ ions [7] provides post-epithelial protec-
tion of the mucous membrane maintaining adequate
blood flow and trophism of the esophageal submu-
cous membrane. Therefore, the imbalance and/or
deficiency of these ions are capable of disrupting the
processes of neuromuscular transmission and mus-
cles contraction which, in its turn, manifests in the
form of gastroesophageal (GER) and duodenogas-
tric (DGR) refluxes [8]. Decrease in magnesium
concentration in the body contributes to a severer
course of GERD and reduction in the quality of
life [9].
The inhomogeneity of Mg2+ and Ca2+ distribu-
tion in different tissues of the body, its predominant
content inside the cells complicate diagnose of their
deficiency only by blood content. According to the
literature data, a decrease in their content in blood
serum occurs only in case of a clear deficiency of
these ions. According to the scientific literature,
the determination of magnesium and calcium in red
blood cells is more informative in comparison with
their determination in blood serum [9, 10].
Concurrently, the dynamics of Mg2+, Ca2+ lev-
els and the activity of matrix metalloproteinases
under the influence of magnesium and calcium-
containing drugs have not been studied in the pa-
tients with GERD associated with UCTD.
The objective of the research was to study the
effectiveness of course application of magnesium
and calcium-containing drugs on the background of
conventional therapy on the changes in the content
of macronutrients in red blood cells and the activity
of matrix metalloproteinase-9 in the patients with a
combination of UCTD and GERD.
1. Materials and Methods
The research was conducted at the Therapeutic De-
partment No 2 of Ivano-Frankivsk Central City Clin-
ical Hospital (CCCH) and the University Clinic of
the Ivano-Frankivsk National Medical University
(IFNMU). The research included 120 patients. The
study group consisted of 75 patients with GERD
associated with UCTD. All the patients were di-
vided into three subgroups depending on the pro-
posed treatment regimen. The first group (Group
I) included 25 patients who received Magne-B6
at a dose of 2 tablets 3 times a day in addition to
the standard background therapy with Panocid at a
dose of 40mg once a day. The second group (Group
II) consisted of 25 patients who received Ca-D3
Nycomed at a dose of 1 tablet 3 times a day in
addition to the standard background therapy. The
third group (Group III) included 25 patients who
received a combination of Magne-B6 and Ca-D3
Nycomed in addition to the standard background
therapy. The control group consisted of 25 patients
with GERD without UCTD symptoms. Twenty ap-
parently healthy individuals were also examined.
The concentration of MMP-9 in blood serum
was determined in all the examined subjects in-
cluded into the research by the immune-enzyme
method using Immuno Chem-2100 Microplate
Reader with the use of the RayBiotech Human
MMP-9 Ensyme Immunoassay Kit (USA) and was
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stated in pg/ml. Atomic absorption spectrophotom-
etry (AAS) was applied with the use of C-115PK
instrument in order to study the content of Mg2+
and Ca2+ in the packed red blood cells. The method
is based on the diffusion of a mineralized agent so-
lution in air-acetylene flame and the measurement
of the resonant absorption of atoms of the studied
element. All examinations were performed before
the treatment and 1 month after the treatment.
Statistical processing of the obtained results
was performed using the STATISTICA 7.0. and
the statistical package of the Microsoft Excel 2016
program. The significance of the obtained results
was confirmed on the basis of the calculation of
Student’s coefficient. Correlation analysis was con-
ducted according to Pearson correlation coefficient.
The quantitative characteristics were described us-
ing arithmetic mean (M), standard error (± m), and
interquartile range: lower - higher quartile (LQ-
HQ).
When working with patients, we adhered to
the ethical principles of the Helsinki Declaration
of World Medical Association adopted in 1964
(amended in 2000), the Charter of the Ukrainian
Association for Bioethics and Good Clinical Prac-
tice (GCP) Standards (1992), in accordance with the
requirements and standards of the CCI GCP (2002),
the Model Regulations of the Ethics Committee ap-
proved by the Ministry of Health of Ukraine No
66 dated 13.02.2006. Before being included into
the research, all the patients signed a voluntary in-
formed consent to participate in the research and
were fully aware of the methods and the scope of
the research. The research was approved by the
Bioethics Committee of the IFNMU.
2. Results
The indices of magnesium and calcium content in
the patients with GERD associated with UCTD be-
fore the treatment are presented in Table 1.
According to the data presented in Table 1, Mg2+
level in red blood cells was 1.3 times lower in the
patients of the study group in comparison with the
patients without comorbid pathology and 1.6 times
lower as compared to healthy individuals (p∧<0.05;
p*<0.05). The level of Ca2+ in red blood cells in
the patients with GERD associated with UCTD was
1.68 times lower as compared to the patients, who
were diagnosed with GERD without concomitant
pathology and 1.8 times lower in comparison with
healthy individuals (p∧<0.05; p*<0.05). MMP-9
content in such patients constituted 3608.5±77.43,
1561.389±71.77 and 1442.84±87.80 pg/ml on av-
erage, respectively (p∧<0.05; p*<0.05).
Therefore, the obtained data confirmed that mag-
nesium and calcium deficiency was noted in case of
GERD as an independent disease as well as in case
of its combination with UCTD causing an increase
in MMP-9 activity. Moreover, severer alteration of
Mg2+ and Ca2+ levels and MMP-9 activity occurred
in the patients with GERD associated with UCTD
and required the inclusion of drugs capable of influ-
encing the detected changes in the complex therapy
for this comorbid condition.
The dynamics of Mg2+ and Ca2+ content in red
blood cells under the influence of the proposed com-
plex therapy is presented in Fig. 1 and Fig. 2.
According to the data presented in Fig. 1, the
inclusion of Magne-B6 in the conventional therapy
in the patients of Group I promoted a more signifi-
cant increase in Mg2+ in red blood cells by 40.9%
from 14.123±1.362 µg/g to 19.4±1.239 µg/g, and
it was higher by 1.45 µg/g as compared to the con-
trol group, although it did not reach the level of
healthy individuals. Ca2+ level in red blood cells
did not change significantly in the patients of this
group, although it increased to 61.3±4.16 µg/g
(Fig. 2). Mg2+ dynamics was less significant in the
patients of Group II, who received Ca-D3 Nycomed
in addition to the background therapy; this index
reached the level of 17.9±2.04 µg/g (p”>0.05).
In its turn, Ca2+ level significantly increased to
80.6±2.12 µg/g (p”<0.05) in these patients in com-
parison with the data before the treatment, but it
still remained lower by 11.5% in comparison with
the control group and by 18.9% as compared to
healthy individuals. Mg2+ and Ca2+ indices showed
the most significant positive dynamics in Group
III, where Magne-B6 and Ca-D3 Nycomed were
included in the background therapy. In particu-
lar, magnesium content reached 21.52±2.47 µg/g
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Table 1. Mg2+ and Ca2+ content in red blood cells and MMP-9 in the blood plasma of the examined
patients (M±m).
Study group Control group,
Healthy individuals,
GERD + UCTD (GERD)
n=75 n=25 n=20
before the treatment
Mg2+ (µg/g) 14.123±1.362* ∧ 18.450±1.419 21.9±2.739
Ca2+ (µg/g) 53.323±1.089* ∧ 89.862±0.789 99.5±0.189
MMP-9 pg/ml 3608.5±77.43*∧ 1561.389±71.77 1442.84±87.80
Notes:
* – (p<0.05) the data are reliable in comparison with the indices of healthy individuals;
∧ – (p<0.05) the data are reliable in comparison with the control group.
Figure 1. Dynamics of Mg2+ content in red blood cells in the examined patients under the influence of
concurrent correction.
Note: ” – (p<0.05) the data are reliable with regard to the indices before and after the treatment.
increasing by 1.16 times as compared to the con-
trol group and approaching the indices of group
with healthy individuals (p”<0.05). Ca2+ index
also increased by 1.9 times on average reaching
102.7±1.37 µg/g. This index increased by 12.5%
on average in comparison with the control group
and almost reached the indices of group with healthy
individuals (p”<0.05).
The initial data on the level of MMP-9 in the
patients with UCTD and GERD as well as GERD
as an independent pathology before the inclusion
in the treatment are presented in Fig. 3. Accord-
ing to the presented data, MMP-9 concentration
in the patients with combined pathology was 2.5
times higher than in healthy individuals and 1.9
times higher in comparison with the patients with
GERD without connective tissue lesions. While
MMP-9 level in healthy individuals ranged from
1442.84±87.80, Me of this index constituted
3399.283 among the patients with comorbid pathol-
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Figure 2. Dynamics of Ca2+ content in red blood cells in the examined patients under the influence of
corrective treatment.
Note: ” – (p<0.05) the data are reliable with regard to the indices before and after the treatment.
ogy; Mo was 3091.61 with interquartile range (LQ-
HQ) constituting 3081.201-4039.798 pg/ml. Me
was 1561.389; Mo constituted 1602.151;
LQ-HQ=1014.925-1973.303 in the group of the
patients with GERD without connective tissue le-
sions.
A correlation analysis before the treatment found
the existence of a strong negative relations between
MMP-9 levels and Mg concentration and MMP-9
and Ca in red blood cells. This confirmed the data
that Mg2+ deficiency led to an increase in MMP-9
collagenase activity [11, 12].
We monitored the dynamics of changes in MMP-
9 level after the provided combination treatment
with the inclusion of the methods of trace element
metabolism correction in the background therapy
(Table 2, Fig. 4). The average value of this index in
the patients of Group I decreased by 39.45% in com-
parison with the initial data reaching
2184.835±36.12 pg/ml (p”<0.05) and remaining
1.3 times higher in comparison with the same index
of the control group and 1.5 times higher than the
average value of this index in healthy individuals
(Fig. 4). The average value of MMP-9 in the pa-
tients of Group II decreased by 35.3% as compared
to the initial data and reached 2335.018±27.34
pg/ml (p”<0.05). According to the presented data,
the improvement of Mg2+ deficiency reduced MMP-
9 concentration by 4.16% more on average in com-
parison with the introduction of Ca2+. MMP-9 level
decreased by 53.18% in comparison with the ini-
tial data and amounted to 1689.266±14.89 pg/ml
with an interquartile range of 1483.781-1990.542
approaching the level of the control group in the
patients of Group III who underwent the improve-
ment of Mg2+ and Ca2+ levels alongside with the
standard background therapy. Thus, according to
the obtained data, it can be argued that simultane-
ous inclusion of both drugs in the standard therapy
for GERD in the patients with UCTD had a more
significant effect on MMP-9 index.
3. Discussion
The results of the research indicated that GERD
as an independent disease and in combination with
UCTD manifests as diselementosis thereby increas-
ing the activity of MMP-9. Moreover, more sig-
nificant abnormalities of Mg2+ and Ca2+ levels in
red blood cells and MMP-9 activity were noted in
comorbidity requiring the inclusion of the drugs
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Figure 3. MMP-9 level in the patients before the treatment.
Notes:
* – (p<0.05) the data are reliable in comparison with the indices of healthy individuals;
∧ – (p<0.05) the data are reliable between the study groups.
Figure 4. Interquartile ranges of MMP-9 in the examined patients after the treatment.
Note: ”– (p<0.05) the data are reliable with regard to the indices before and after the treatment.
capable of influencing changes detected in combi-
nation therapy for such comorbidity. The obtained
data were consistent with the results obtained by
other authors [13, 14]. According to the research
of G.I. Nechaeva and co-authors [5], magnesium
deficiency was noted in 47.84% of the patients and
calcium deficiency was detected in 64.1% of the
patients with connective tissue disease. Mg2+ defi-
ciency leads to an increase in MMP-9 collagenase
activity, and according to the scientific data, it accel-
erates the degradation of the structural components
of intracellular matrix, primarily collagen. This ef-
fect is apparently related to the inhibitory effect of
magnesium ions on MMP by competitive binding
of divalent cations in their active center. Accord-
ing to Ahvazi B. (2004) et al., insufficient content
of Mg2+ in the body alongside with the increased
expression of collagenases reduces the activity of
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Table 2. Influence of combination therapy with the inclusion of magnesium and calcium on MMP-9
level.
MMP-9 (pg/ml)
The examined group Me±m Mo LQ-HQ
Before the treatment, n=75 3608.5±77.43 3399.283 2501.5-5132.402
After the treatment
Group I, n=25 2184.835±36.12” 2067.887 1590.203-3039.798
Group II, n=25 2335.018±27.34” 2067.887 1927.092-2998.601
Group III, n=25 1689.266±14.89” 1627.092 1483.781-1990.542
Control group, n=25 1561.389±71.77 1602.151 1014.925-1973.303
Healthy individuals, n=20 1442.84±87.80 1590.203 1014.925-1655.609
Note: ”– (p<0.05) the data are reliable with regard to the indices before and after the treatment.
elastase leading to an increase in the concentration
of flexible elastin fibers. Ca2+ has a significant
effect on elastin fibers as well; its sufficient level
helps stabilize microfibril structure. Elastin chains
are joined by transglutaminase activated by Ca2+
and inhibited by Mg2+ [11, 12]. Mg2+ can inhibit
copper-dependent lysyl oxidase (LOX). Therefore,
the occurrence of ”pathological” lateral sutures of
collagen and elastin chains is possible in case of
Mg2+ deficiency resulting in connective tissue gran-
ularization in case of increased MMP activity. Thus,
the most likely scheme of Mg2+ and Ca2+ deficiency
to influence the connective tissue is to enhance the
destruction of collagen and elastin fibers as well
as to break the bond between them. Therefore, the
prevention of appearing new lateral sutures requires
special attention by providing a sufficient concentra-
tion of Mg2+ and Ca2+ in the body since the suture
appearance leads to an emergence of pathological
connective tissue, whereas the sufficient concen-
tration of Mg2+ and Ca2+ decreases the activity of
PPM-9, degradation, and increases the synthesis of
new collagen molecules, which was confirmed in
our research.
4. Conclusions
Based on the data obtained, it can be argued that si-
multaneous addition of ”Magne-B6” and
”Ca-D3 Nikomed” to the standard therapy for gas-
troesophageal reflux disease in the patients with
NDST contributed to a significant decrease in the
level of MMP-9 resulting in reduced degradation
and increasing synthesis of new connective tissue
components.
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